Baron Opportunity Fund Q4 2024 Shareholder Letter
Source: SeekingAlpha
2025-02-04 07:50:00 ET
Summary
- Baron Opportunity Fund increased in the fourth quarter of 2024, outperforming its benchmark, the Russell 3000 Growth Index.
- Top contributors were Tesla, Inc., NVIDIA Corporation, and Space Exploration Technologies Corp.
- Top detractors were Viking Therapeutics, Inc., Rocket Pharmaceuticals, Inc., and Microsoft Corporation. We exited our position in Rocket Pharmaceuticals.
- We added several new holdings, including networking solutions company Arista Networks, Inc., independent broker-dealer LPL Financial Holdings Inc., and medical device company Inari Medical, Inc.
Dear Baron Opportunity Fund Shareholder:
During the fourth quarter, Baron Opportunity Fund® (the Fund) rose 11.92% (Institutional Shares), significantly outperforming the Russell 3000 Growth Index (the Benchmark), which advanced 6.82%, and the S&P 500 Index, which gained 2.41%. For the full year 2024, the Fund posted solid returns, climbing 40.25%, beating the Benchmark, which rose 32.46%, and the S&P 500 Index, which improved 25.02%.
Table I. Performance† - Annualized for periods ended December 31, 2024
| Baron Opportunity Fund Retail Shares1,2 | Baron Opportunity Fund Institutional Shares1,2,3 | Russell 3000 Growth Index 1 | S&P 500 Index 1 | |
|---|---|---|---|---|
| Three Months 4 | 11.86% | 11.92% | 6.82% | 2.41% |
| One Year | 39.89% | 40.25% | 32.46% | 25.02% |
| Three Years | 6.07% | 6.34% | 9.93% | 8.94% |
| Five Years | 20.33% | 20.65% | 18.25% | 14.53% |
| Ten Years | 17.87% | 18.17% | 16.22% | 13.10% |
| Fifteen Years | 16.08% | 16.39% | 16.11% | 13.88% |
| Since Inception(February 29, 2000) | 10.07% | 10.25% | 7.69% | 8.06% |
Read the full article on Seeking Alpha
For further details see:
Baron Opportunity Fund Q4 2024 Shareholder Letter
Baron Capital Enterprise Inc
NASDAQ: BCAP
BCAP Trading
0.0% G/L:
$0.0001 Last:
4,700,000 Volume:
$0.0001 Open:
